Clinical Trial Update: Doxycycline in Cutaneous Schwannoma (NF2) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating doxycycline for cutaneous schwannomas in Neurofibromatosis Type 2, sponsored by Massachusetts Eye and Ear Infirmary. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Neurofibromatosis Type 2 | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING